IA
MBX

IFP Advisors’s MBX Biosciences MBX Stock Holding History

IFP Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$30 – 5318
2026
Q1 		$30 Hold
1
– – ﹤0.01% 4889
2025
Q4 		$32 Buy
+1
New +$24 ﹤0.01% 4758

Other funds holding MBX

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

IFP Advisors's MBX Position: Q2 2026 in Review

IFP Advisors sold out of MBX Biosciences (MBX) in Q2 2026, closing a stake of 1 share — an estimated $30 sold.

IFP Advisors first reported a position in MBX in Q4 2025 and held it in 2 quarters. The position peaked at $32 in Q4 2025. 16 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • IFP Advisors reported no remaining MBX Biosciences position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 1 MBX Biosciences share in Q2 2026, an estimated $30.
  • IFP Advisors first reported a position in MBX Biosciences in Q4 2025 and held it in 2 quarters.
  • IFP Advisors's MBX Biosciences position peaked at $32 in Q4 2025.
  • 16 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.